# OmniSonics Medical Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/omnisonics-medical-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Lakewood, US
- Website: www.omnisonics.com
- Total disclosed funding: $100M
- Latest round: Series D (Jun 13, 2007)
- Investors on record: 13

## About

OmniSonics Medical Technologies, Inc. develops innovative medical devices focused on enhancing patient care in minimally invasive procedures by utilizing advanced sonic technology to improve outcomes and increase safety for patients.OmniSonics Medical Technologies, Inc. specializes in medical device technology aimed at improving minimally invasive surgery. The company was founded in 1998 and is headquartered in Lakewood, US. In February 2011, it underwent a significant transition when it was acquired by Cybersonics Sound Technologies after filing for Chapter 9 bankruptcy in March 2009. The firm has engaged in a total of 8 deals, with its most recent deal occurring on February 7, 2011. The company raised a total of USD 10.020 mn, with the latest funding round amounting to USD 10.020 mn, attracting investors such as Canaan Partners, Domain Associates, General Electric Pension Trust, and Prism Venture Management.OmniSonics Medical Technologies offers a range of advanced medical devices designed to optimize the performance of minimally invasive surgical procedures. The company's technologies leverage sonic energy to enhance the efficacy and safety of various surgical interventions, ultimately benefiting healthcare providers and patients alike.OmniSonics Medical Technologies has a revenue model focused on the sales of its innovative medical devices, with purchases typically occurring on a one-time basis. These devices are marketed primarily to healthcare institutions and surgical centers, facilitating improved surgical outcomes. The firm implements flexible payment options, which may include installment plans, thereby accommodating diverse purchasing needs in the medical field.Looking ahead, OmniSonics Medical Technologies plans to further develop its product line, with an emphasis on launching new medical technologies tailored for minimally invasive surgery. The firm aims to expand its presence in North America, Europe, and Asia, targeting specific markets by leveraging recent investments to bolster research and development initiatives. Recent funding will be allocated to these growth strategies, as the company seeks to enhance its product offerings and increase market penetration following its acquisition in 2011.

## Funding rounds

- Series D, Jun 13, 2007, $20M — Domain Associates, New England Partners, Canaan Partners, Johnson & Johnson Innovation, Tekla Capital Management, Phase4 Partners
- Series B, Jun 11, 2007, $10M — Domain Associates, Prism Venture Management, New England Partners, Canaan Partners, General Electric Pension Trust, Johnson & Johnson Innovation, Nomura Asset Management, Hambrecht & Quist
- Series C, Mar 2, 2004, $43M — Domain Associates, Prism Venture Management, New England Partners, Canaan Partners, General Electric Pension Trust, Virtus Investment Partners, Johnson & Johnson Innovation, MIC Capital, Tekla Capital Management, Nomura Asset Management
- Series B, May 30, 2001, $21M — Domain Associates, Prism Venture Management, Canaan Partners, JP Morgan Asset Management
- Series A, Jul 18, 2000, $5.7M — Prism Venture Management, Johnson & Johnson Innovation

## Investors

- Prism Venture Management (https://capitalatlas.ai/funds/prism-venture-management) — Series A, Series B, Series C
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A, Series C, Series B, Series D
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B, Series C, Series D
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series B, Series C, Series D
- JP Morgan Asset Management (https://capitalatlas.ai/funds/jp-morgan-asset-management) — Series B
- New England Partners (https://capitalatlas.ai/funds/new-england-partners) — Series C, Series B, Series D
- General Electric Pension Trust — Series C, Series B
- Virtus Investment Partners — Series C
- MIC Capital — Series C
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series C, Series D
- Nomura Asset Management (https://capitalatlas.ai/funds/nomura-asset-management) — Series C, Series B
- Hambrecht & Quist (https://capitalatlas.ai/funds/hambrecht-quist) — Series B
- Phase4 Partners (https://capitalatlas.ai/funds/phase4-partners) — Series D